Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $20.13 USD
Change Today +0.04 / 0.20%
Volume 1.1M
MNTA On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Bruce A. Leicher J.D.

Senior Vice President, General Counsel and Corporate Secretary , Momenta Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

58--

Background*

Mr. Bruce A. Leicher, J.D., has been Senior Vice President and General Counsel at Momenta Pharmaceuticals Inc. since July 2008. Mr. Leicher has been Secretary of Momenta Pharmaceuticals Inc. since September 2008. Mr. Leicher served as Senior Vice President, Secretary and General Counsel of Altus Pharmaceuticals Inc. from December 19, 2006 to July 18, 2008. Mr. Leicher has over 15 years experience in providing counsel in the life sciences industry. He has 25 years of ...

Read Full Background

Corporate Headquarters*

675 West Kendall Street
Cambridge, Massachusetts 02142

United States

Phone: 617-491-9700
Fax: 617-621-0431

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Bachelor's Degree
University of Rochester
BA
University of Rochester
JD
Georgetown University Law School
LLB
Georgetown University Law School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MNTA:US $20.13 USD +0.04

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Friedhelm Blobel Ph.D.Chief Executive Officer, President, Executive Director and Member of Business Development Committee
SciClone Pharmaceuticals, Inc.
$550.0K
Douglas A. Michels Chief Executive Officer, President and Director
OraSure Technologies, Inc.
$580.1K
Yongfeng Zhang Ph.D.Chief Executive Officer, Chief Science Officer and Director
Amphastar Pharmaceuticals, Inc.
$1.4M
Peter S. Greenleaf Chief Executive Officer and Director
Sucampo Pharmaceuticals, Inc.
$440.2K
Rajeev Nannapaneni Vice Chairman, Chief Executive Officer, Chief Operating Officer and Member of Allotment Committee
Natco Pharma Limited
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MOMENTA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.